New copper chelates and hydrazones show promise against Ehrlich ascites carcinoma in mice. Concurrent administration with copper ions significantly enhanced survival times, highlighting a potential therapeutic strategy.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: